BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. May 21, 2026; 32(19): 117166
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.117166
Table 3 Initial treatment modalities and clinical outcomes of patients with eosinophilic gastroenteritis, n (%)
Variable/outcome
Gastroduodenitis (n = 34)
Enterocolitis (n = 35)
Gastroenterocolitis (n = 4)
Initial treatment type
PPI9 (26.5)2 (5.7)-
Steroid12 (35.3)23 (65.7)3 (75.0)
PPI + steroid5 (14.7)1 (2.9)-
PPI + antihistamines1 (2.9)--
PPI + steroid + antihistamines1 (2.9)--
Steroid + antihistamines-1 (2.9)-
Antihistamines-1 (2.9)-
Conservative treatment6 (17.6)7 (20.0)1 (25.0)
Clinical outcomes
Clinical response27/32 (84.4)28/31 (90.3)3/4 (75.0)
Relapse4/29 (13.8)13/30 (43.3)0/4 (0)


Write to the Help Desk